October 1, 2020
“PDC Energy (PDCE)… Are other analysts in agreement? They are. Only Buy ratings, 11, in fact, have been issued in the last three months. Therefore, the verdict is unanimous: PDCE is a Strong Buy. Given the $21.50 average price target,… Continue Reading…
September 17, 2020
“Akero Therapeutics (AKRO)… Are other analysts in agreement? They are. Only Buy ratings, 6, in fact, have been issued in the last three months. Therefore, the message is clear: AKRO is a Strong Buy. Given the $58.50 average price target,… Continue Reading…
September 2, 2020
“Baudax Bio (BXRX) First up we have Baudax Bio, which is a pharmaceutical company focused on developing and commercializing innovative products for acute care settings. With shares changing hands for $2.80, Oppenheimer believes that the share price presents an attractive… Continue Reading…
September 5, 2019
““We were looking for a correction in August, but we believe the market will rally into the end of the year,” Matejka said in an interview. “The key call is that the U.S. is not headed for a recession. The… Continue Reading…
Recent Comments